INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 August 2011
|
Total net assets |
£92.3m |
|
NAV per share |
164.9p |
|
Share price |
143.0p |
|
Total value of unquoted investments |
£23.3m |
|
Total number of portfolio companies |
66 |
|
Cash |
(10)% NAV |
|
Cash committed and reserved to unquoted investments |
(10)% NAV |
|
Portfolio companies with < 1 year of cash |
13% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen |
5.9 |
|
Cadent |
5.4 |
|
Teva |
5.3 |
|
Gilead Sciences |
5.1 |
|
Insulet |
4.3 |
|
Pharmasset |
4.3 |
|
Celgene |
4.1 |
|
Shire |
4.0 |
|
Micromet |
3.3 |
|
Axis-Shield |
3.3 |
|
|
----------- |
|
Total |
45.0 |
|
Geographical Allocation |
% |
|
United States |
85 |
|
Europe |
18 |
|
Israel |
5 |
|
Australia |
2 |
|
Cash |
(10) |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
85 |
|
Unquoted |
25 |
|
Cash |
(10) |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
14 SEPTEMBER 2011